博拓生物
(688767)
| 流通市值：10.23亿 | | | 总市值：27.10亿 |
| 流通股本：4026.67万 | | | 总股本：1.07亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,765,904,542.46 | 1,907,430,695.68 | 1,865,818,271.38 | 1,812,780,881 |
| 应收票据及应收账款 | 60,565,920.29 | 61,888,543.95 | 68,243,252.72 | 54,103,480.43 |
| 应收账款 | 60,565,920.29 | 61,888,543.95 | 68,243,252.72 | 54,103,480.43 |
| 预付款项 | 1,961,065.57 | 1,306,934.64 | 10,316,022.1 | 8,075,218.45 |
| 其他应收款合计 | 3,392,848.66 | 2,796,215.41 | 5,089,200.72 | 3,979,240.49 |
| 存货 | 81,513,475.04 | 99,323,982.27 | 112,977,301.52 | 118,399,663.09 |
| 一年内到期的非流动资产 | - | 10,000,000 | - | - |
| 其他流动资产 | 5,861,397.5 | 4,061,685.92 | 7,271,540.04 | 20,090,987 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,919,199,249.52 | 2,086,808,057.87 | 2,069,715,588.48 | 2,017,429,470.46 |
| 非流动资产: | | | | |
| 长期股权投资 | 2,553,965.42 | 2,840,500.33 | 3,300,000 | - |
| 投资性房地产 | 4,856,010.76 | 4,931,115.87 | 3,964,853.09 | 4,092,643.38 |
| 固定资产 | 383,339,067.77 | 220,573,094.57 | 227,524,864.1 | 231,643,916.98 |
| 在建工程 | 39,763,629.07 | 39,654,454.76 | 4,063,649.85 | 4,016,480.03 |
| 使用权资产 | 693,210.71 | 1,349,421.63 | 3,650,490.69 | 4,939,355.25 |
| 无形资产 | 207,368,231.41 | 208,709,743.09 | 210,647,179.75 | 212,225,007.81 |
| 长期待摊费用 | 81,340.63 | 108,266.15 | 137,188.03 | 165,680.37 |
| 递延所得税资产 | 14,791,801.98 | 14,442,223.54 | 11,258,422.28 | 13,057,732.1 |
| 其他非流动资产 | 1,537,300 | 153,378.29 | 20,000,000 | 40,399,000 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 654,984,557.75 | 492,762,198.23 | 484,546,647.79 | 510,539,815.92 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,574,183,807.27 | 2,579,570,256.1 | 2,554,262,236.27 | 2,527,969,286.38 |
| 流动负债: | | | | |
| 短期借款 | 347,555.03 | 588,768.99 | 179,815.43 | 551,867.87 |
| 应付票据及应付账款 | 56,813,724.17 | 58,353,267.93 | 51,008,817.14 | 50,444,595.6 |
| 应付账款 | 56,813,724.17 | 58,353,267.93 | 51,008,817.14 | 50,444,595.6 |
| 合同负债 | 44,656,651.08 | 47,155,882.37 | 43,563,741.26 | 44,814,147.8 |
| 应付职工薪酬 | 10,158,497.68 | 17,610,860.61 | 8,272,539.53 | 8,233,655.49 |
| 应交税费 | 5,387,075.99 | 3,139,326.09 | 11,366,467.9 | 11,060,042.08 |
| 其他应付款合计 | 21,766,990.1 | 19,621,102.85 | 3,879,097.55 | 4,048,988.53 |
| 一年内到期的非流动负债 | 1,791,133.53 | 2,450,197.1 | 2,694,239.48 | 3,500,359.14 |
| 其他流动负债 | 203,336.97 | 506,258.7 | 130,828.54 | 91,063.71 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 141,124,964.55 | 149,425,664.64 | 121,095,546.83 | 122,744,720.22 |
| 非流动负债: | | | | |
| 租赁负债 | - | 0 | 456,231.42 | 1,143,982.37 |
| 递延收益 | 11,338,942.55 | 8,686,884.48 | 8,985,070.48 | 9,238,227.97 |
| 递延所得税负债 | 708,330.62 | 708,330.62 | 840,880.68 | 927,985.01 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 12,047,273.17 | 9,395,215.1 | 10,282,182.58 | 11,310,195.35 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 153,172,237.72 | 158,820,879.74 | 131,377,729.41 | 134,054,915.57 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 106,666,667 | 106,666,667 | 106,666,667 | 106,666,667 |
| 资本公积 | 813,332,050.99 | 813,332,050.99 | 814,938,492.34 | 814,938,492.34 |
| 减:库存股 | 54,292,506.12 | 14,764,220.79 | - | - |
| 其他综合收益 | -105,760.44 | -355,939.32 | 2,123,567.92 | 2,238,609.64 |
| 盈余公积 | 53,333,333.5 | 53,333,333.5 | 53,333,333.5 | 53,333,333.5 |
| 未分配利润 | 1,496,662,941.37 | 1,457,031,592.78 | 1,441,973,604.3 | 1,412,048,593.03 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,415,596,726.3 | 2,415,243,484.16 | 2,419,035,665.06 | 2,389,225,695.51 |
| 少数股东权益 | 5,414,843.25 | 5,505,892.2 | 3,848,841.8 | 4,688,675.3 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,421,011,569.55 | 2,420,749,376.36 | 2,422,884,506.86 | 2,393,914,370.81 |
| 负债和股东权益合计 | 2,574,183,807.27 | 2,579,570,256.1 | 2,554,262,236.27 | 2,527,969,286.38 |
| 公告日期 | 2024-04-27 | 2024-04-27 | 2023-10-28 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |